Departure. Clinical Miss. Billion: Should You Bet on Pfizer?
Pfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Explore the best credit cards that provide cash back without any fees. Start saving more on your purchases!
26,647 articlesPfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
A veteran's take on holding (onon) 2025 earnings: what to watch, where margins could move, and how to plan for the Q4...
Ultra-safe funds show shrinking income while principal remains flat, challenging the notion of a truly safe retiremen...
Polestar stock plunged 29% in a single week. There was no obvious single news trigger, but a mix of market forces and...
Netflix just posted a record quarterly revenue, but the forecast for the next quarter came in softer than expected. H...
The Nasdaq may be hovering near a correction, but smart planning helps investors navigate volatility. Here are four e...
ASML dominated the latest quarter with strong results and higher guidance. This article breaks down what that could m...
Sandisk has surged as AI infrastructure gains grab headlines. But can the rally last? This article lays out 3-year sc...
Intel stunned investors with a triple-digit rally in early 2026. This guide breaks down why intel stock soared 278%, ...
A major asset manager boosted its stake in Boot Barn, signaling confidence in the westernwear retailer. This piece br...
When berkshire hathaway just made a surprising Alphabet bet, investors sit up and take notice. This article explains ...
Republic Services is tightening up near key moving averages, raising odds for a golden cross. This report surveys the...